ENTX · NASDAQ · Biotechnology

Entera Bio

Develops oral peptide therapies through its N-Tab delivery platform.

$3.03
After-hours close−0.01 (−0.33%)
At close$3.04(−1.30%)
DateEstimateReportedSurprise
Nov 2026−$0.08
Aug 2026−$0.08−$0.14−75.0%
May 2026−$0.08−$0.07+12.5%
Mar 2026−$0.09−$0.07+22.2%
Nov 2025−$0.09−$0.07+22.2%

The latest year is open to everyone — the 38 quarters behind it read with an account.

Sign in
Aug 2025
May 2025
Mar 2025
Nov 2024
Aug 2024
May 2024
Mar 2024
Nov 2023
Aug 2023
May 2023
Mar 2023
Nov 2022
Aug 2022
May 2022
Mar 2022
Nov 2021
Aug 2021
May 2021
Mar 2021
Nov 2020
Aug 2020
May 2020
Mar 2020
Nov 2019
Aug 2019
Jun 2019
Mar 2019
Jan 2019
Aug 2018
Jun 2018
Mar 2018
Sep 2017
Jun 2017
Mar 2017
Dec 2016
Sep 2016
Jun 2016
Mar 2016
Report dateEPS estEPSSurpriseRevenue estRevenueSurprise
Nov 13, 2026−$0.08
Aug 7, 2026−$0.08−$0.14−75.0%$0
May 8, 2026−$0.08−$0.07+12.5%
Mar 27, 2026−$0.09−$0.07+22.2%
Nov 14, 2025−$0.09−$0.07+22.2%

The latest year is open to everyone — the 38 quarters behind it read with an account.

Sign in
Aug 8, 2025
May 9, 2025
Mar 28, 2025
Nov 8, 2024
Aug 9, 2024
May 10, 2024
Mar 8, 2024
Nov 14, 2023
Aug 11, 2023
May 5, 2023
Mar 27, 2023
Nov 10, 2022
Aug 11, 2022
May 12, 2022
Mar 8, 2022
Nov 10, 2021
Aug 16, 2021
May 20, 2021
Mar 18, 2021
Nov 19, 2020
Aug 20, 2020
May 21, 2020
Mar 26, 2020
Nov 21, 2019
Aug 20, 2019
Jun 27, 2019
Mar 28, 2019
Jan 22, 2019
Aug 20, 2018
Jun 29, 2018
Mar 31, 2018
Sep 30, 2017
Jun 30, 2017
Mar 31, 2017
Dec 31, 2016
Sep 30, 2016
Jun 30, 2016
Mar 31, 2016